Advarra, a regulatory review solutions and clinical research technology provider for sites and sponsors, has been awarded an Indefinite Delivery, Indefinite Quantity (IDIQ) contract worth $13,999,465.00 from the National Institutes of Health’s (NIH’s) National Institute of Allergy and Infectious Diseases (NIAID). It entails providing project management and administrative oversight as the institutional review board (IRB) of record for the Biorepository Protocol and U.S. domestic sites for s...